The 20 Best Brain Tumor Doctors Near Me in District of Columbia, US

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is rated as an Elite provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Sahebjam is board certified in American Board Of Internal Medicine.

Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Breast Cancer, and Pancreatic Cancer. Dr. Croog is board certified in American Board Of Radiology.

Matthew Ladra, M.D., M.P.H., leads the dedicated pediatric team for the Johns Hopkins Proton Therapy Center and is the director of pediatric radiation oncology for the Johns Hopkins Kimmel Cancer Center, a clinical collaboration with Children’s National Hospital, where Dr. Ladra serves as faculty in the department of pediatric oncology. He is also an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine. Listen Dr. Ladra's Cancer Matters podcast episode to learn more about his work. Previously, Dr. Ladra served as the director of pediatric radiation at the Provision Center for Proton Therapy in Tennessee. He also completed a 2-year fellowship in pediatric proton therapy at the Massachusetts General Hospital’s Francis H. Burr Proton Center. Dr. Ladra is one of a handful of radiation oncologists whose research and clinical efforts focus exclusively on pediatric patients. He is frequently invited to speak on pediatric radiation oncology topics internationally and across the U.S. and has published extensively on the subject through original research book chapters and review articles. Dr. Ladra’s research efforts focus mainly on pediatric rhabdomyosarcoma treatment, early phase clinical trials involving radiation and non-chemotherapeutic agents, and reducing neurocognitive toxicity for pediatric brain tumor patients. LinkedIn https://www.linkedin.com/in/matthew-ladra-3094a316. Dr. Ladra is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Muscle Invasive Bladder Cancer, Adult Soft Tissue Sarcoma, and Ependymoma. Dr. Ladra is board certified in American Board Of Radiology.

Deepa Subramaniam is an Internal Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Subramaniam is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer. Dr. Kumar is board certified in American Board Of Radiology.

Marie Kate Gurka, M.D., is a radiation oncologist in the Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Gurka has expertise in radiation treatment for breast cancer and gynecologic cancers. Dr. Gurka earned her medical degree from Virginia Commonwealth University and completed a residency in radiation oncology at Georgetown University Hospital. She previously served as an instructor in the Department of Radiation Oncology at University of Louisville and has conducted both clinical and basic science research. Her work has been recognized by the American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO), and it has been cited in various lectures, research articles, and textbooks. Washingtonian Magazine and Bethesda Magazine have repeatedly named Dr. Gurka a Top Doctor. Selected Publications Oermann EK, Bhandari R, Chen V, Lebec G, Gurka M, Lei S, Chen L, Suy, S, Azumi N, Berkowitz F, Kalhorn C, McGrail K, Collins BT, Jean W, Collins SP. Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas. Frontiers in Radiation Oncology. 2013; 3: 213. Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Stereotactic Body Radiation Therapy with Concurrent Full-Dose Gemcitabine for Locally Advanced Pancreatic Cancer: A Pilot Trial Demonstrating Safety. Radiation Oncology. 2013; 8: 44. Gurka MK, Kim C , Carroll J, Charabaty A, Haddad M, Jackson P, Collins SP, Marshall J, Pishvaian MK, Unger KR. Stereotactic Body Radiation Therapy (SBRT) combined with chemotherapy for unresected pancreatic adenocarcinoma. American Journal of Clinical Oncology. 2014; 152-157. Gurka MK, Horne ZD, Ju A, Chen L, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch JH, Collins SP. Hematuria Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer. Radiation Oncology. 2015; 10:44. Gurka MK, Pender D, Chuong P, Fouts B, Sebelov A, McNally M, Mezera M, Woo SY, McNally R. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. Journal of Controlled Release. 2016; 231:60-67. Dr. Gurka is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Gliomatosis Cerebri, and Marginal Zone Lymphoma (MZL). Dr. Gurka is board certified in American Board Of Radiology.

Dr. Carmen Kut is a radiation oncologist with expertise in the treatment of head and neck cancer and central nervous system cancers. She is passionate about patient-centered care, finding the best plan for each patient through targeted therapies, including proton therapy, when appropriate. In addition to her clinical expertise, Dr. Kut is an innovative researcher, conducting translational research in biomedical engineering to help bring new treatment options to her patients. In particular, she is interested in utilizing innovative imaging technologies to enable precision radiotherapy. Dr. Kut is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Subependymoma, Glioma, and Gliomatosis Cerebri.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kressel is board certified in American Board Of Internal Medicine.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, and Prostatectomy. Dr. Deville is board certified in American Board Of Radiology.

Daniel A. Donoho, MD, received an undergraduate degree from Dartmouth College (economics) and medical degree from SUNY- Stony Brook, where he was elected to the Alpha Omega Alpha Honor Medical Society. Dr. Donoho’s research included clinical and translational research in neuroendocrinology, including studies investigating growth hormone replacement and oxytocin function. Dr. Donoho completed his internship and neurological surgery residency at the University of Southern California where he learned from the mentorship of renowned surgeons including Steven L. Giannotta, MD, J. Gordon McComb MD and Martin Weiss, MD He has published over 50 manuscripts and book chapters and given many presentations and invited lectures on innovations in adult and pediatric brain and spinal disorders. During his residency, he completed a prestigious fellowship in endoscopic, minimally disruptive surgery for tumors and other conditions of the skull base under the tutelage of Edward R. Laws, Jr. MD at Harvard Medical School. Following completion of his post-graduate training, he completed a top-tier subspecialty fellowship in pediatric neurosurgery at Texas Children’s Hospital and he was a clinical instructor in the Baylor College of Medicine. Dr. Donoho is excited to join Children’s National Hospital and George Washington University as an assistant professor of pediatric neurosurgery. His clinical interests include brain tumors, pituitary tumors and craniopharyngiomas, rathke’s cleft cysts, spinal tumors, hydrocephalus, myelomeningocele, spina bifida, Chiari malformation, spinal malformations and trauma, spinal dysraphism and craniocervical spinal disorders. He is available for pediatric and prenatal consultations in person and via telehealth. Dr. Donoho’s research appointments are in the faculty of the George Washington University School of Medicine and Health Sciences, the Children’s National Center for Neuroscience Research and the Sheikh Zayed Institute for Pediatric Surgical Innovation. His research group studies surgical education and technological innovations that improve surgical safety. He founded one of the first neurosurgical computer vision research groups with mentors and collaborators at the University of Southern California and Caltech where he maintains an active collaboration. He is currently engaged in studies of surgeon performance using computer vision and machine learning. Dr. Donoho is eligible for certification by the American Board of Neurological Surgery (ABNS) and the American Board of Pediatric Neurosurgery (ABPNS). Publications Google Scholar. Dr. Donoho is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Metopic Ridge, Craniosynostosis, Sunken Fontanelles, Endoscopic Transnasal Transsphenoidal Surgery, and Laminectomy. Dr. Donoho is board certified in American Board Of Neurological Surgery, 2024.

Hasan R. Syed, MD, was born in Morganton, NC and raised outside of Washington, D.C. He graduated as valedictorian of his high school class and attended Virginia Commonwealth University (VCU) as a Presidential Scholar in the Honors College. While in Richmond, he majored in Biomedical Engineering and graduated summa cum laude. He remained at VCU to complete his medical degree, where he was elected to the Alpha Omega Alpha Honor Medical Society. During this time, Dr. Syed was awarded funding through the Office of Research for a master’s degree to investigate cancer stem cell biology at King's College London. Dr. Syed completed his internship and neurological surgery residency at Georgetown University under Kevin McGrail, MD He received numerous awards during his training, including the resident traveling fellowship from the AANS/CNS Section on pediatric neurosurgery, and published manuscripts, book chapters and delivered oral presentations on both adult and pediatric brain and spinal disorders. Following completion of his post-graduate training, he relocated to Chicago to complete a prestigious subspecialty fellowship in pediatric neurosurgery at Ann & Robert H. Lurie Children's Hospital, Northwestern University under renowned pediatric neurosurgeon Tad Tomita, MD After spending three years at the University of Virginia as an assistant professor and associate residency program director, Dr. Syed joined Children’s National Hospital as an associate professor and fellowship director with a focus in pediatric neurosurgery. His clinical interests include brain and spinal tumors, hydrocephalus, craniosynostosis, Chiari malformation, epilepsy, spinal dysraphism, spasticity, craniocervical spinal disorders, peripheral nerve injuries and Moyamoya disease. He also has a strong interest in minimal access surgeries for brain and spinal disorders in pediatric patients. Dr. Syed is certified by the American Board of Neurological Surgery (ABNS) and the American Board of Pediatric Neurosurgery (ABPNS). Outside of work, his interests include traveling and spending time with his family in Washington, D.C. Dr. Syed is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Metopic Ridge, Craniosynostosis, Spinal Fusion, and Laminectomy. Dr. Syed is board certified in American Board Of Neurological Surgery, 2020.

Robert Keating, MD, is currently a McCullough distinguished professor, interim senior vice president, Neuroscience and Behavioral Medicine Center and chief of Neurosurgery at Children’s National Hospital. A graduate of Georgetown University Medical School, he completed a neurosurgery residency and fellowship in pediatric neurosurgery/craniofacial surgery at the Albert Einstein and Montefiore Medical Center in the Bronx, NY. Following his training, Dr. Keating served in the U.S. Navy and was stationed at the Oakland Naval Hospital serving as the chief from 1991-1994. After his time in the Navy, he returned to the Bronx where he was on staff at Montefiore Medical Center as well as the Bronx Municipal Hospital Center for two years before coming back to Washington, D.C., in 1996 to join the faculty at Children’s National Dr. Keating's past appointments include the president of the medical staff at Children’s National, as well as head of credentials. He currently maintains a busy practice of pediatric neurosurgery, with an emphasis on tumors, Chiari malformations, craniofacial reconstruction, spinal dysraphism, spasticity and brachial plexus surgery. As a member of the American Society of Pediatric Neurosurgery and International Society of Pediatric Neurosurgery, he has published and presented extensively in the field. His publications include the previous texts, “An Atlas of Orbitocranial Surgery” and “Tumors of the Pediatric Nervous System” (2nd edition published in 2013), with current work on Neurosurgical Operative Atlas, (2nd ed. Goodrich JT, and Keating RF, Thieme) due for publication in 2018. He is also chair, medical advisory committee on the Board of the American Syringomyelia Alliance Project as well as a founding member of the Posterior Fossa Society and maintains long-standing membership in the CNS, AANS, ASPN and ISPN. Dr. Keating is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Craniosynostosis, Metopic Ridge, Chiari Malformation Type 1, Posterior Fossa Decompression, and Craniectomy. Dr. Keating is board certified in Neurological Surgery: American Board Of Neurological Surgery, 2000 and Neurological Surgery: American Board Of Neurological Surgery, 1993.

Abdullah Feroze, MD, is a neurosurgeon at Children’s National Hospital and an assistant professor of neurosurgery at George Washington University. Dr. Feroze specializes in the care of children and adults with complex neurosurgical conditions. His expertise spans the full spectrum of pediatric neurosurgical care, including: Management of brain and spine tumors Congenital anomalies Hydrocephalus Spine disorders Epilepsy Spasticity Vascular anomalies He serves as a tireless advocate for his patients and their families, providing not only surgical excellence, but unwavering guidance and support through their respective treatment journeys. One of a select few neurosurgeons in North America with specialized training in both pediatric and adult open cerebrovascular and endovascular techniques, he has a keen interest in providing comprehensive and compassionate treatment for a wide range of congenital and acquired cerebrovascular diseases, including: Brain aneurysms Arteriovenous malformations Idiopathic intracranial hypertension Vein of Galen malformations Stroke Moyamoya disease Dr. Feroze employs a tailored approach to each patient's unique needs in conjunction with a dedicated multidisciplinary team, ensuring the most effective and safest possible outcomes. A graduate of the Stanford University School of Medicine, Dr. Feroze completed neurosurgical residency at the University of Washington/Harborview Medical Center and subsequent fellowships at Harvard Medical School (Brigham & Women’s Hospital/Boston Children’s Hospital) and Children’s National. He is an active member of the American Association of Neurological Surgeons, Society for Neurointerventional Surgery and the International Society of Pediatric Neurosurgery. He remains involved in the realm of health policy advocacy, with prior engagements at the World Health Organization and the White House. His research efforts in brain tumor immunotherapy, global health disparities and vascular neurosurgery have been recognized in multiple publications including The Lancet, Forbes Magazine, Nature Biotechnology, and Science Translational Medicine. In his spare time, he enjoys tennis, mountaineering and gardening. Publications: ORCID PUBMED. Dr. Feroze is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Central Pain Syndrome, Brain Tumor, Gliomatosis Cerebri, Craniectomy, and Endovascular Embolization. Dr. Feroze is board certified in American Board Of Pediatrics, 2022.

Peter Ahn is a Radiation Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Ahn is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Sinus Cancer, Teratocarcinosarcoma, and Throat Cancer.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Sara Inati is a Neurologist practicing medicine in Washington, Washington, D.c.. Dr. Inati is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Epilepsy, Seizures, Absence Seizure, Generalized Tonic-Clonic Seizure, and Deep Brain Stimulation.

Nam Nguyen is an Internal Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Prostate Cancer, Familial Prostate Cancer, and Throat Cancer. Dr. Nguyen is currently accepting new patients.

Edina Komlodi is a Neurologist practicing medicine in Washington, Washington, D.c.. Dr. Komlodi is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Embryonal Tumor with Multilayered Rosettes, Glioma, and Glioblastoma.